Safety and Feasibility of Intravenous Paracetamol for Patent Ductus Arteriosus in Indomethacin-/Ibuprofen-Resistant or -Contraindicated Preterm Infants: A Case Series

Background  Although indomethacin and ibuprofen are the standard treatments for hemodynamically significant patent ductus arteriosus (hsPDA), they are associated with renal impairment and gastrointestinal complications. Paracetamol for hsPDA closure does not provoke a peripheral vasoconstrictive eff...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:AJP Rep
Autors principals: Oshima, Ayumi, Matsumura, Shun, Iwatani, Ayaka, Morita, Machiko, Fujinuma, Sumie, Motojima, Yukiko, Tanaka, Kosuke, Masutani, Satoshi, Kabe, Kazuhiko, Ueda, Keiko, Namba, Fumihiko
Format: Artigo
Idioma:Inglês
Publicat: Thieme Medical Publishers 2020
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7056395/
https://ncbi.nlm.nih.gov/pubmed/32140292
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1055/s-0040-1702945
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars